Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Newamsterdam Pharma Company ORDINARY SHARES | 9,212,384 | 9,198,900 | -13,484 | $262.00M | $322.70M | 42.30% | +$60.70M |
| Dyne Therapeutics, Inc.(DYN) | 5,462,846 | 5,462,846 | 0 | $69.11M | $106.85M | 14.01% | +$37.75M |
| Engene Holdings Inc COM | 9,632,561 | 9,632,561 | 0 | $65.79M | $86.98M | 11.40% | +$21.19M |
| Rapt Therapeutics Inc | 344,237 | 1,833,333 | +1,489,096 | $8.88M | $62.09M | 8.14% | +$53.22M |
| MapLight Therapeutics, Inc.(MPLT) | 0 | 3,226,400 | +3,226,400 | $0 | $56.67M | 7.43% | +$56.67M |
| Vor Biopharma Inc.(VOR) | 379,640 | 3,617,354 | +3,237,714 | $18.50M | $47.31M | 6.20% | +$28.82M |
| Replimune Group, Inc.(REPL) | 4,158,368 | 2,808,368 | -1,350,000 | $17.42M | $27.30M | 3.58% | +$9.87M |
| Bicycle Therapeutics PlcADS | 3,452,330 | 3,468,430 | +16,100 | $26.72M | $24.56M | 3.22% | -$2.16M |
| Crescent Biopharma, Inc.(CBIO) | 0 | 1,677,852 | +1,677,852 | $0 | $19.90M | 2.61% | +$19.90M |
| Engene Holdings IncW EXP 10 31 2028 *W EXP 10/31/202 | 2,878,148 | 2,878,148 | 0 | $2.07M | $8.52M | 1.12% | +$6.45M |
| Astria Therapeutics Inc | 4,107,537 | 0 | -4,107,537 | $29.90M | $0 | — | -$29.90M |